Showing results (141-150 of 242) with videos related to
Sort By:
Pageof 25
Scandinavian Journal of Immunology|January 1, 1976
Partial tolerant state against H-2 disparate cells. No impaired specific reactivity in MLC, GVH, or antibody productionH Jacobsson, B Lilliehöök, H BlomgrenActa Radiologica: Therapy, Physics, Biology|April 1, 1975
Capacity of sera from patients with mammary carcinoma to promote PHA-stimulation of human lymphocytesH Blomgren, J Wasserman, U GlasScandinavian Journal of Immunology|January 1, 1976
Complex nature of the production of 'effector' cells and their interaction with target cells in the M-antigen system of the mouseB Lilliehöök, H Jacobsson, H BlomgrenAnticancer Research|March 1, 1991
Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro. Its potential use in the treatment of superficial bladder cancerH Blomgren, M Hallström, H HillgrenAnticancer Research|July 1, 1985
Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor typeH Blomgren, U Blom, H UllénJournal of Clinical & Laboratory Immunology|March 1, 1981
Radiosensitivity of Hodgkin's disease lymphocytesE Baral, H Blomgren, S RotsteinScandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Cyclophosphamide-prednisolone therapy in advanced prostatic carcinomaL Andersson, F Edsmyr, P L Esposti, et al.The New England Journal of Medicine|March 7, 1985
Cancer risks in patients with chronic lymphocytic thyroiditisL E Holm, H Blomgren, T LöwhagenRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1985
Interferon therapy in disseminated renal cell carcinomaF Edsmyr, P L Esposti, L Andersson, et al.Acta Medica Scandinavica|January 1, 1979
Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytesS Einhorn, H Blomgren, K Cantell, et al.Pageof 25